Creo Medical awarded with Gold RoSPA Award

This is an internationally recognised award that celebrates the hard work and achievements of the Creo team in the management of the health, safety and welfare for our employees and others working for us.

This is an internationally recognised award that celebrates the hard work and achievements of the Creo team in the management of the health, safety and welfare for our employees and others working for us.

Creo provided evidence to support action on 19 detailed sections covering our health and safety performance and management, including; Leadership, Policies, Employee Engagement and Communication, Competence and Training, Risk Assessment, Monitoring and Auditing, Contractor Management, Incident Reporting and Investigation, Corporate Reporting, Emergency Preparedness and how we have responded to the challenges of the Covid-19 pandemic.

This is the second year running that we have been awarded the Gold award, testament to the practices we continue to implement across the business.

More about RoSPA and their work here:  About – RoSPA

Posted 03/30/22

For press enquiries please contact media@creomedical.com. For all other enquiries please visit our Contact page.

Further news

19 March 2024

Welsh Labour Leader visits Creo’s facilities

Read

05 February 2024

Strategic Collaboration with Khalifa University of Science and Technology, Abu Dhabi

Read

31 January 2024

Roll-out of Speedboat® UltraSlim reaches Asia Pacific

Read

10 January 2024

First Use of Speedboat® UltraSlim in Latin America

Read

13 December 2023

First European Speedboat® UltraSlim procedure marks early commercial launch

Read

01 November 2023

Speedboat® UltraSlim: US FDA Clearance

Read

25 October 2023

Speedboat UltraSlim: EU launch accelerated by 18 months

Read

12 September 2023

Half Year Report: H1-2023

Read

19 June 2023

Speedboat Inject cleared for upper GI use in Europe

Read

01 June 2023

Speedboat™ Inject selected by NICE for assessment

Read